Clinical trial
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
NCT07060950 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Circulating Tumor Markers in Blood - ALCINA 5
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2025
- Completion date
- July 31, 2035
- Enrollment
- 620 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, lung cancer, non-small cell